Literature DB >> 18437055

A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo.

Shuyi Yu1, Juping Duan, Zhiqun Zhou, Qiong Pang, Ji Wuyang, Ting Liu, Xiaowen He, Liu Xinfa, Yuxiang Chen.   

Abstract

Tumor cell migration and metastasis are critically regulated by chemokines and their receptors. CC Chemokine Receptor 7 (CCR7) plays a critical role in mediating chemotactic and invasive responses in cancers. However, whether or not CCR7 is a desired target of cancer therapy needs further investigation in terms of its biodegradation and availability in vivo. In this study, we employed RNA interference technology to detect the in vitro effects of anti-CCR7 siRNAs on proliferation and invasiveness of SW620 cells. We also evaluated the ability of these siRNAs to inhibit the lymphogenesis and the lymph node metastasis in xenografted SW620 tumor mouse. The chemotaxis and invasion assay in the animal model showed that blocking CCR7 expression at the mRNA level by a siRNA impaired invasion of colon cancer cells and inhibited lymph node metastasis of colon cancer and lymphogenesis. Therefore, CCR7 might be a desired target for cancer therapy and novel drug development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437055     DOI: 10.4161/cbt.7.7.6065

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  15 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  Identification of functional modules that correlate with phenotypic difference: the influence of network topology.

Authors:  Jui-Hung Hung; Troy W Whitfield; Tun-Hsiang Yang; Zhenjun Hu; Zhiping Weng; Charles DeLisi
Journal:  Genome Biol       Date:  2010-02-26       Impact factor: 13.583

Review 3.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

4.  CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells.

Authors:  Limei Sun; Qingfu Zhang; Yang Li; Na Tang; Xueshan Qiu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

Review 5.  Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.

Authors:  Gregory P Takacs; Joseph A Flores-Toro; Jeffrey K Harrison
Journal:  Pharmacol Ther       Date:  2020-12-11       Impact factor: 12.310

6.  CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells.

Authors:  Ying Xu; Lifeng Liu; Xueshan Qiu; Lili Jiang; Bo Huang; Haiying Li; Zixuan Li; Wenting Luo; Enhua Wang
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

Review 7.  Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.

Authors:  Simona L Schlereth; Nasrin Refaian; Sandra Iden; Claus Cursiefen; Ludwig M Heindl
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

Review 8.  The role of chemoattractant receptors in shaping the tumor microenvironment.

Authors:  Jiamin Zhou; Yi Xiang; Teizo Yoshimura; Keqiang Chen; Wanghua Gong; Jian Huang; Ye Zhou; Xiaohong Yao; Xiuwu Bian; Ji Ming Wang
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

Review 9.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21

10.  CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.

Authors:  Lirong Zhang; Dongqing Wang; Yumei Li; Yanfang Liu; Xiaodong Xie; Yingying Wu; Yuepeng Zhou; Jing Ren; Jianxin Zhang; Haitao Zhu; Zhaoliang Su
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.